Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
US Department of Justice
Harvard Business School
Dow
Chubb
Cantor Fitzgerald
Merck
Citi
Mallinckrodt

Generated: April 23, 2018

DrugPatentWatch Database Preview

PIRMELLA 1/35 Drug Profile

« Back to Dashboard

Which patents cover Pirmella 1/35, and when can generic versions of Pirmella 1/35 launch?

Pirmella 1/35 is a drug marketed by Lupin Ltd and is included in one NDA.

The generic ingredient in PIRMELLA 1/35 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for PIRMELLA 1/35
Drug patent expirations by year for PIRMELLA 1/35

US Patents and Regulatory Information for PIRMELLA 1/35

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd PIRMELLA 1/35 ethinyl estradiol; norethindrone TABLET;ORAL-28 201512-001 Apr 24, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Chinese Patent Office
Julphar
Healthtrust
Farmers Insurance
UBS
Harvard Business School
McKinsey
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.